SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-23-000046
Filing Date
2023-04-25
Accepted
2023-04-25 07:30:13
Documents
5
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a230425-6k.htm 6-K 13860
2 99.1 FINANCIAL REPORT Q1 2023 a230425-99_1.htm EX-99 176832
3 99.2 INTERIM FINANCIAL REPORT a230425-99_2.htm EX-99 1209650
4 IMAGE logo.jpg GRAPHIC 26773
5 IMAGE coverifr.jpg GRAPHIC 307039
  Complete submission text file 0001370368-23-000046.txt   1861091
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 23841758
SIC: 2834 Pharmaceutical Preparations